Literature DB >> 19940035

Renin-angiotensin system activation in renal adipogenesis.

Yi Sui1, Hai-Lu Zhao, Rong-Rong Fan, Jing Guan, Lan He, Heung Man Lee, Juliana C N Chan, Peter C Y Tong.   

Abstract

The kidney is one of the major organs involved in whole-body homeostasis while chronic renal impairment usually leads to fat redistribution and hyperlipidemia. The aim of this study was to elucidate the role of tissue renal renin-angiotensin system (RAS) components, lipogenic peroxisome proliferator-activated receptor-gamma (PPARgamma), and cytokine TNF-alpha in the development of ectopic adipogenesis and lipid deposition. Adult male Sprague-Dawley rats were randomized into three groups: untreated uninephrectomized (UNX) rats, UNX rats treated with an angiotensin-converting enzyme inhibitor (ACEI), lisinopril, and sham-operated rats. All animals were euthanized at 10 mo postoperation. The untreated UNX rats showed increased protein expression of renin, angiotensinogen, PPARgamma, and the angiotensin II type 2 receptor (AT2R) but reduced protein expression of AT1R and TNF-alpha in their remnant kidneys. Immunofluorescence staining revealed increased reactivity of angiotensinogen and angiotensin I/II in renal tubular cells and adipocytes of the untreated UNX rats. ACEI treatment largely prevented these disorders in association with restored normolipidemia and normalized renal adipogenesis and lipid deposition. These findings support the notion that tissue RAS, PPARgamma, and TNF-alpha collectively play an important role in the renal adipogenesis and lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940035     DOI: 10.1152/ajprenal.00445.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

Review 1.  Risk for cancer in living kidney donors and recipients.

Authors:  Min Wang; Huai Zhang; Dan Zhou; Yong-Chao Qiao; Yan-Hong Pan; Yan-Chao Wang; Hai-Lu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-22       Impact factor: 4.553

Review 2.  Metabolic rate regulation by the renin-angiotensin system: brain vs. body.

Authors:  Justin L Grobe; Kamal Rahmouni; Xuebo Liu; Curt D Sigmund
Journal:  Pflugers Arch       Date:  2012-04-12       Impact factor: 3.657

3.  Metabolic imaging of human kidney triglyceride content: reproducibility of proton magnetic resonance spectroscopy.

Authors:  Sebastiaan Hammer; Aiko P J de Vries; Paul de Heer; Maurice B Bizino; Ron Wolterbeek; Ton J Rabelink; Joost Doornbos; Hildo J Lamb
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors:  Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

5.  Cross-talk between AMP-activated protein kinase and renin-angiotensin system in uninephrectomised rats.

Authors:  Ke-Ke Yang; Yi Sui; Hui-Rong Zhou; Jian Shen; Ning Tan; Yan-Mei Huang; Sha-Sha Li; Yan-Hong Pan; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-10-26       Impact factor: 1.636

6.  Uninephrectomy in rats on a fixed food intake results in adipose tissue lipolysis implicating spleen cytokines.

Authors:  Denis Arsenijevic; Jean-François Cajot; Abdul G Dulloo; Jean-Pierre Montani
Journal:  Front Physiol       Date:  2015-07-10       Impact factor: 4.566

7.  Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan.

Authors:  Basma Ismail; Robert A deKemp; Tayebeh Hadizad; Kumiko Mackasey; Rob S Beanlands; Jean N DaSilva
Journal:  EJNMMI Res       Date:  2016-06-23       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.